Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
2.
Front Oncol ; 12: 812008, 2022.
Article in English | MEDLINE | ID: mdl-35651809

ABSTRACT

Penile cancer (PC) still presents a health threat for developing countries, in particular Brazil. Despite this, little progress has been made on the study of markers, including molecular ones, that can aid in the correct management of the patient, especially concerning lymphadenectomy. As in other neoplasms, non-coding RNAs (ncRNAs) have been investigated for penile cancer, with emphasis on microRNAs, piRNAs (PIWI-interacting small RNAs), and long non-coding RNAs (LncRNAs). In this context, this review aims to assemble the available knowledge on non-coding RNA linked in PC, contributing to our understanding of the penile carcinogenesis process and addressing their clinical relevance. ncRNAs are part of the novel generation of biomarkers, with high potential for diagnosis and prognosis, orientating the type of treatment. Furthermore, its versatility regarding the use of paraffin samples makes it possible to carry out retrospective studies.

4.
Transl Androl Urol ; 10(5): 2019-2026, 2021 May.
Article in English | MEDLINE | ID: mdl-34159082

ABSTRACT

BACKGROUND: Human papillomavirus (HPV) infection is a risk factor for penile cancer (PC). The miR-145 expression has been correlated to this virus genomic amplification. In this context, this work aims to determine the expression level of miR-145 in penile tumors infected by high-risk HPV and correlate it with the clinicopathological characteristics of the tumor and protein expression of p53. METHODS: Formalin-fixed paraffin-embedded from 52 patients with PC, at diagnosis and prior to any cancer treatment, were obtained. HPV identification was performed by nested type PCR, and miR-145 expression was obtained by qRT-PCR. Immunohistochemical analysis of p53 and Ki-67 was performed. RESULTS: Tumoral miR-145 expression was significantly lower compared to adjacent tissue. Additionally, there was a significant reduction of miR-145 expression in invasion perineural, histological associated HPV, and absence of p53 expression in positive HPV cases. HPV infection was detected in 86.5%, the most frequent HPV16. Reduced disease-free survival was observed in patients with low expression of miR-145. CONCLUSIONS: Our data suggest that the underexpression of miR-145 may be triggered by HPV action, decreasing protein expression of p53, and being correlated with perineural invasion. Therefore, the deregulation of miR-145 provides clues as to the potential role in penile carcinogenesis and is also a potential candidate for validation in noninvasive samples.

5.
Asian Pac J Cancer Prev ; 21(2): 391-397, 2020 Feb 01.
Article in English | MEDLINE | ID: mdl-32102516

ABSTRACT

BACKGROUND: Inguinal lymph node involvement is the main prognostic factor in patients with penile cancer. However, there is a lack of marker/s for lymph node metastasis. microRNAs have been investigated as potential markers for prognosis of various types of cancer. Taking this into consideration, our main goal was to determine the association of miR-223-3p, miR-107, and miR-21-5p expression with clinicopathological characteristics, as well as presence of lymph node metastasis in patients with penile cancer. METHODS: Formalin-fixed paraffin-embedded penile squamous cell carcinoma specimens from 50 patients, at diagnosis and prior to any cancer treatment, were obtained. Tissue samples comprising at least 70% malignant cells and adjacent non-tumor tissues were evaluated by using qRT-PCR for expression level of miR-223-3p, miR-107 and miR-21-5p. Additionally, molecular identification of HPV was performed by PCR, and the expression levels of PTEN were analyzed by immunohistochemistry. RESULTS: Penile squamous cell carcinoma primary tumors presented higher expression of miR-223-3p, miR-107, and miR-21-5p when compared to non-tumor adjacent tissues. Upregulation of miR-223-3p was associated lymph node metastasis. Higher expression of miR-107 was associated with worsening of prognosis (as observed by histological grade II and III, tumors bigger than 2.0 cm, stage III and IV, and lower disease-free survival). In addition, higher expression of miR-107 and miR-21-5p was correlated to the absence of PTEN protein expression. CONCLUSIONS: Our data demonstrate that higher expression of miR-223-3p, miR-107, and miR-21-5p is correlated with poor prognosis in penile cancer. The upregulation of these microRNAs potentially affect critical cancer pathways and may be important for the prognosis and response to therapy in penile cancer.


Subject(s)
Biomarkers, Tumor/genetics , Carcinoma, Squamous Cell/pathology , Gene Expression Regulation, Neoplastic , MicroRNAs/genetics , Penile Neoplasms/pathology , Biomarkers, Tumor/metabolism , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/surgery , Follow-Up Studies , Gene Expression Profiling , Humans , Male , Middle Aged , PTEN Phosphohydrolase/metabolism , Penile Neoplasms/genetics , Penile Neoplasms/metabolism , Penile Neoplasms/surgery , Prognosis
6.
PLoS One ; 13(10): e0205350, 2018.
Article in English | MEDLINE | ID: mdl-30312320

ABSTRACT

BACKGROUND: Infection with human papillomavirus (HPV) is reported to be present in 30-50% of penile cancer cases. The immunohistochemical test for p16INK4a is used as an indicator of the presence of HPV and as a prognostic marker for squamous cell carcinomas in various sites. However, the role of this marker in penile carcinoma has not yet been completely elucidated. The aim of this study was to analyze whether the expression of p16INK4a is associated with the presence of HPV, histological parameters, and survival in penile cancer. METHODS: A study was conducted from 2014 to 2016 that included 55 patients with penile carcinoma. HPV DNA was detected through PCR using fresh tumor tissue, and immunohistochemistry was performed for analysis of p16INK4a protein using paraffin-embedded tissue. Evaluation of histological parameters was performed following complete embedding of the tumor tissue in paraffin. RESULTS: HPV DNA (low-risk and high-risk genotypes) was found in 49 (89.1%) cases, and 46/49 (93.9%) showed high-oncogenic risk HPV (HR-HPV). Of the 22 cases positive for p16INK4a, HR-HPV DNA was present in 21 (95.5%) (p = 0.032). Regarding histological parameters, p16INK4a and HR-HPV were significantly associated only with tumor subtype (p = 0.036 and p = 0.032, respectively); all carcinomas with basaloid characteristics were positive for p16INK4a. Although HPV+ patients had a higher disease-free survival (p <0.001), p16INK4a expression was not associated with patient survival. CONCLUSIONS: Our study, using fresh tissue samples, showed the highest incidence of HPV compared to that observed in the literature. Expression of the p16INK4a protein was significantly associated with the presence of HR-HPV and this expression may serve as a marker for the presence of the virus. The p16INK4a protein was not associated with the histological prognostic parameters, with the exception of tumor subtype, nor with patient survival. In the results, we showed that the objective of the present study was reached.


Subject(s)
Biomarkers, Tumor/genetics , Cyclin-Dependent Kinase Inhibitor p16/genetics , Papillomavirus Infections/genetics , Penile Neoplasms/genetics , Aged , Carcinogenesis/genetics , Gene Expression Regulation, Neoplastic , Genotype , Human papillomavirus 6/pathogenicity , Humans , Male , Middle Aged , Papillomavirus Infections/complications , Papillomavirus Infections/pathology , Papillomavirus Infections/virology , Penile Neoplasms/complications , Penile Neoplasms/pathology , Penile Neoplasms/virology
7.
Open educational resource in Portuguese | CVSP - Brazil | ID: una-10123

ABSTRACT

O vídeo fala sobre o câncer de próstata, o que é a próstata e para que serve, os tipos de doenças da próstata, estimativa de novos casos (INCA) 2017, fatores, risco, diagnóstico, tratamento e exames periódicos para detecção precoce.


Subject(s)
Prostatic Hyperplasia , Prostatic Neoplasms
8.
Rio de Janeiro; s.n; 2013. 68 p. ilus, tab, graf.
Thesis in Portuguese | LILACS | ID: lil-708327

ABSTRACT

A testosterona tem sido cada vez mais usada em homens na fase do envelhecimento como prevenção e tratamento de doenças metabólicas, melhora do desempenho sexual, proteção cardiovascular e manutenção da cognição. Porém ainda há conflito sobre seus efeitos na próstata com relação às doenças benignas e malignas. O presente estudo avaliou o efeito do tratamento com duas formas de testosterona sobre carcinoma de próstata induzido por N-Metil-N-Nitrosureia (NMU) a partir de análises histopatológicas e séricas do antígeno prostático específico (PSA). Para tal foram utilizados 80 ratos Wistar jovens, sadios, divididos em dois grupos (40 animais cada) tratados ou não com NMU intraperitoneal. Cada grupo foi dividido em quatro subgrupos iguais e tratados durante 16 semanas: 1) tratado com cipionato de testosterona a cada sete dias via intramuscular; 2) tratado com cipionato de testosterona a cada 14 dias via intramuscular; 3) tratado com undecanoato de testosterona oral diariamente; 4) tratado com óleo mineral. Após 16 semanas e tratamento, os níveis do PSA não alteraram em nenhum grupo ou subgrupo e não houve desenvolvimento de tumores em nenhum deles. Portanto, as duas formas distintas de testosterona associada ao uso de NMU em curto espaço de tempo por via intraperitoneal não alteraram as dosagens séricas do PSA e não induziram a formação de tumores na próstata em ratos Wistar jovens e saudáveis. As alterações histopatológicas acinares encontradas nas próstatas foram projeção, secreção, congestão e inflamação, e as epiteliais foram: epitélio normal, redução do epitélio e redução na altura do mesmo. Tais achados colaboram para que outros estudos sejam realizados de maneira a orientar o uso de testosterona na prática clinica diária sem receio de indução do câncer na próstata.


Testosterone has been increasingly used in men during the aging process as prevention and treatment of metabolic diseases, improving sexual performance, cardiovascular protection and maintenance of cognition. But there are still conflicted about its effects in the prostate with respect to benign and malignant diseases. The present study evaluated the effect of treatment with two forms of testosterone on prostate carcinoma induced by N-methyl-N-nitrosourea (NMU) from pathological examinations and serum prostate-specific antigen (PSA). For this we used 80 young Wistar rats, healthy, divides into two groups (40 animals each) or not treated with intraperitoneal NMU. Each group was divided into four equal subgroups and treated for 16 weeks: 1) treated with testosterone cypionate every seven days intramuscularly, 2) treated with testosterone cypionate every 14 days intramuscularly, 3) treated with oral testosterone undecanoate daily, 4) treated with mineral oil. After 16 semanas and treatment, PSA levels did not change in either group or sub-group and no tumor development in any of them. Therefore, two different forms of testosterone associated with the use of NMU in short time intraperitoneally did not affect the serum PSA and did not induce tumor formation in prostate in young healthy rats. Acinar histopathological changes were found in the prostates projection, secretion, congestion and inflammation, epithelial and were normal epithelium, epithelial reduction and reduction in height thereof. These findings collaborate to further studies are performed in order to guide the use of testosterone in daily clinical practice without fear of inducing prostate cancer.


Subject(s)
Animals , Rats , Prostate/physiology , Prostate/pathology , Testosterone/therapeutic use , Prostate-Specific Antigen/analysis , Prostate-Specific Antigen/blood , Epithelial Cells/cytology , Methylnitrosourea/administration & dosage , Methylnitrosourea/therapeutic use , Prostatic Neoplasms/chemically induced , Prostatic Neoplasms/drug therapy , Rats, Wistar
9.
J. bras. med ; 72(5): 145-6, 149-50, maio 1997. ilus
Article in Portuguese | LILACS | ID: lil-196733

ABSTRACT

O sarcoma botrióide é uma neoplasia maligna que acomete os órgäos pélvicos. Os autores relatam o caso mais recente de sarcoma botrióide de bexiga, diagnosticado no Hospital do Câncer do Maranhäo (Hospital Aldenora Bello), discutindo seu diagnóstico, tratamento e aspectos anatomopatológicos.


Subject(s)
Humans , Male , Child, Preschool , Rhabdomyosarcoma, Embryonal/pathology , Urinary Bladder Neoplasms/pathology , Rhabdomyosarcoma, Embryonal/surgery , Urinary Bladder Neoplasms/surgery
10.
J. bras. urol ; 14(1): 39-40, jan.-mar. 1988. ilus
Article in Portuguese | LILACS | ID: lil-52845

ABSTRACT

Os autores descrevem uma nova técnica de correçäo de hipospádia em tempo único, utilizando retalho pediculado ao meato original, de fácil execuçäo e com resultados satisfatórios. O índice de sucesso doi de 69,2%


Subject(s)
Humans , Male , Hypospadias/surgery , Surgical Flaps , Methods
11.
HFA publ. téc. cient ; 2(4): 297-302, out.-dez. 1987. tab, ilus
Article in Portuguese | LILACS | ID: lil-59268

ABSTRACT

Face aos problemas inerentes à vida sexual, e tendo em vista as consequências psicossociais que acomentem os pacientes portadores de impotência sexual, Small e Carrion, em 1975, idealizaram uma prótese artificial que implantada nos corpos cavernosos, oferece uma vida sexual satisfatória. Estudou-se 32 casos de impotência sexual; e foi encontrado uma maior incidência na faixa etária de 30-40 anos e como patologia básica a polineuropatia diabética. Apesar da infecçäo ser a complicaçäo mais temida, a única complicaçäo foi a perfuraçäo da parte proximal do corpo cavernoso,que exigiu nova operaçäo para reposicionamento. O incoveniente da ereçäo permanente ocasiona certo constrangimento ao paciente, mas a adaptaçäo é rápida. O tempo médico de internaçäo foi de 48 horas; todos os pacientes dessa série encontram-se psicológicamente satisfeitos, desempenhando salutarmente suas atividades sexuais, sem complicaçöes


Subject(s)
Adult , Middle Aged , Humans , Male , Erectile Dysfunction/surgery , Prostheses and Implants , Erectile Dysfunction/etiology , Diabetic Neuropathies/complications , Penis/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...